The 23rd Annual European Hematology Association Congress was held was held June 14-17, 2018 in Stockholm Sweden. The following are the posters presented by the Bing Center for Waldenstrom's Macroglobulinemia.

Click on the poster to download a full size PDF version. For more information about EHA 2018, please visit https://ehaweb.org/

Genomic and Clinical Characterization of the Role of MYD88 Mutation Status in Waldenstrom's Macroglobulinemia

Zachary Hunter, Jorge Castillo, Joshua Gustine, Steven Treon

Ibrutinib shows prolonged progression-free survival in symptomatic, previously treated patients with MYD88 mutated Waldenstrom’s Macroglobulinemia: Long-term Follow-up of Pivotal Trial (NCT01614821)

Treon SP, Meid K, Gustine J, Bantilan K, Lam J, Dubeau T, Yang G, Xu L, Patterson CJ, Ghobrial I, Laubach JP, Hunter ZR, Palomba ML, Advani R, Castillo JJ.

Ibrutinib Monotherapy in Symptomatic, Treatment-Naive patients with Waldenstrom’s Macroglobulinemia

Steven P. Treon, Joshua Gustine, Kirsten Meid, Guang Yang, Lian Xu, Xia Liu, Maria Demos, Amanda Kofides, Nicholas Tsakmaklis, Jianji G. Chen, Manit Munshi, Gloria Chan, Toni Dubeau, Noopur Raje, Andrew Yee, Elizabeth O’Donnell, Zachary R. Hunter, and Jorge J. Castillo.